Category stocks

Parabilis Medicines Raises $670 Million

Parabilis Medicines raises $670 million in biotech IPO Parabilis Medicines priced its initial public offering at $20 per share, raising $670 million. The offering priced above the $17-to-$19 range Parabilis had marketed earlier. Underwriters also hold a 30-day op